Respiratory syncytial virus is the leading cause of lower respiratory tract infection 12 among infants. RSV is a priority for vaccine development. In this study, we investigate the potential 13 effectiveness of a two-vaccine strategy aimed at mothers-to-be, thereby boosting maternally 14 acquired antibodies of infants, and their household cohabitants, further cocooning infants against 15 infection. We use a dynamic RSV transmission model which captures transmission both within 16 households and communities, adapted to the changing demographics and RSV seasonality of a 17 low-income country. Model parameters were inferred from past RSV hospitalisations, and forecasts 18 made over a 10-year horizon. We find that a 50% reduction in RSV hospitalisations is possible if the 19 maternal vaccine effectiveness can achieve 75 days of additional protection for newborns 20 combined with a 75% coverage of their birth household co-inhabitants (∼7.5% population 21 coverage). 22 30 are over 40 RSV vaccines in development PATH (2018). In particular, two vaccination approaches 31 have been identified as potentially effective: a single dose vaccine aimed at mothers-to-be leading 32 to antibody transfer across the placenta thereby boosting maternally acquired immunity among 33 newborns, and paediatric vaccination aimed directly at infants Modjarrad et al. (2016); World Health 34 Organization (2017). Moreover, it is possible that a prophylactic extended half-life monoclonal 35 antibody could act as a vaccine surrogate whilst replicating the desired effect of a maternal vaccine 36 Zhu et al. (2017); Domachowske et al. (2018). A serious complication in RSV vaccine development 37 has historically been the risk of causing enhanced disease amongst the immunologically naive Chin 38 et al. (1969), therefore it might be more prudent to target a paediatric vaccine at older children with 39 better developed immune systems rather than young infants most at risk of RSV disease Anderson 40 1 of 21
Introduction
Respiratory syncytial virus (RSV) is the most common viral cause of acute lower respiratory infection 25 Nair et al. (2010) . A large majority of children contract RSV by the age of two Glezen et al. (1986); 26 Ohuma et al. (2012) but the chance of developing severe disease from a RSV infection is much 27 greater amongst young infants (<6 months) Hall et al. (2009) and decreases rapidly with the age 28 of the infected. Vaccine development aimed at protecting young children against RSV disease has 29 become a global health priority World Health Organization (2017) . As of December 2018 there Methods). The joint age and household distribution of the population accessing KCH was chosen 156 to match the ongoing findings of the Kilifi Health and Demographic surveillance system (KDHSS; 157 Scott et al. (2012) ). The seasonality of RSV hospitalisations at KCH has historically been erratic 158 with peak months for RSV hospitalisation varying as widely as November to April (appendix 1). 159 Moreover, over the 15 year period we are studying in this paper, there was demographic change 160 in the underlying population both in age profile and household size distribution. We addressed 161 these modelling challenges: first, by rejecting the typical epidemiological modelling assumption that 162 population demographic structure is at equilibrium in favour of directly modelling demographic 163 change, and second, by treating the shifting seasonality of RSV transmission in Kilifi as being driven 164 by an underlying latent random process to be jointly inferred with model parameters. The goal was 165 to account for factors influencing the rate of hospitalisations that changed over the 15 years of 166 study so as to get an unbiased estimate of parameters we assumed were static over the period, 167 such as the person-to-person rate of transmission within a household. We were able to capture 168 the year-to-year variation in hospitalisation, and age profile of the hospitalised, with only six free 169 parameters ( Fig. 2 , Methods, and appendix 1). We were unable to jointly identify the rate of school 170 children contacting other school children with the rate of homogeneous contact among all over 171 one year olds, therefore we considered a range of within school contact rates, and for each value 172 inferred the other six free model parameters and assessed the efficacy of vaccination for a range 173 of MAB vaccine effectiveness values and IRP vaccine coverage values. Each scenario gave similar 174 results for the efficacy of household targeted vaccination (see Supporting Information), therefore 175 we have only presented results in the main Results section for the scenario with the highest rate 176 of within school mixing. At KCH all RSV hospitalisations occurred in the under five year olds with 177 84% of hospitalisations occurring in the under one year olds (Fig. 2 B) . This finding is consistent 178 with the much higher rates of hospitalisation per RSV infection for younger infants Kinyanjui et al. 179 (2015). However, the hospitalisation time series has to also be understood in the context of dynamic 180 RSV transmission and demographic change in the study population. A general trend of increasing 181 hospitalisations between 2002-2009 is at least partially explained by a 16% increase in under ones in 182 the population over that period. The rest of year-to-year variation in hospitalisation was explained 183 by seasonal epidemic dynamics, themselves driven by shifting seasonality (Fig. 2 A; 1) . 184 It is not straight-forward to directly compare the reproductive ratio ( 0 ; usually defined as 185 the number of secondary cases created by an initial 'typical' case in a completely susceptible 186 population) of transmission models with household and age structured contacts to those with only 187 age structure Pellis et al. (2010) . In models with only age structure 0 can be calculated from the 188 Box 1. Vaccination predictions from a simple unstructured RSV epidemic model
The essential idea in this paper is to use antenatal contact between mothers-to-be and health professionals to deploy two separate vaccines: first, a vaccine targeting the mothers-to-be which boosts the duration of protection her newborn will have against RSV (MAB vaccine), and second, a vaccine aimed at the mothers-to-be's household cohabitants giving each a period of RSV immunity, equivalent to that of a natural infection (IRP vaccine). As a baseline for understanding RSV transmission we can use a simple mechanistic model which captures the essential biology of RSV infection; newborns are born with a period of immunity to RSV infection which is lost during their first year of life, after contracting RSV the individual is infectious for a period before gaining temporary waning immunity to RSV re-infection. Assuming homogeneous transmission the dynamics of the simple RSV transmission model can be described using four dynamic variables describing the numbers of currently maternally protected individuals (M), susceptibles (S), infecteds (I) and immune/recovereds (R). The evolution of the epidemic, after vaccination, can be given as a standard ODE:
Where each term above describes the rate of events that change the epidemic state: Births ( ), loss of maternally derived protection, after MAB vaccination, ( ), mortality ( ), RSV force of infection ( ∕ ), recovery ( ), reversion to susceptibility ( ), as standard in the literature Anderson and May (1992) ; Keeling and Rohani (2008) . The rate at which IRP vaccines successfully vaccinate susceptibles is ⟨ ⟩ ∕( + + ); that is the mean size of a pregnant woman's household (⟨ ⟩) times the effective coverage of the vaccine (0 ≤ ≤ 1) time the likelihood of selecting a susceptible and not wasting the vaccine assuming that we are only targeting those who have definitely lost their maternal protection to RSV ( ∕( + + )). For simplicity, we can treat the duration of maternal protection as very short compared to the typical person's lifetime (i.e. ≫ ). The simple RSV model is analytically tractable:
% reduction in transmission due to vaccination = ( + + ) ⟨ ⟩ ( + )( 0 − 1)( + ) Reduction in transmission per IRP vaccine = + 0 ( + + ) Where 0 = ∕( + ) is the reproductive ratio of RSV, and we are assuming that the birth rate is at replacement = . The simple RSV model makes some general predictions about the efficacy of IRP vaccination: Therefore, a naive simple model of RSV transmission is pessimistic about the joint vaccination strategy. However, in this study we also account for more detailed social structure, differential susceptibility, infectiousness, and risk of disease dependent on the age of the individual and seasonality in transmission. We will see that targeting vaccines socially close to young infants is much more effective than the simple model predicts. age-based mixing rates Diekmann et al. (1990) ; the 0 for RSV in Kilifi county has been estimated as 189 high, 0 = 7.1 or 0 = 25.6 depending on how the age-based mixing rates were estimated Kinyanjui 190 et al. (2015) . In principle, our model did not require household transmission for RSV to persist since 191 it would have been possible for us to infer that age-based mixing in the community dominated 192 RSV transmission. However, if we neglect within household transmission from our model with 193 inferred parameters we found the subcritical 0 = 0.75 for solely age-based transmission outside of 194 the household; that is we inferred that within household transmission was necessary to sustain 195 transmission of RSV in the population. 196 We found that, pre-vaccination, school age children suffered on average the highest force of 197 infection, that is the per-capita rate of infectious contacts, from outside of the household followed by 198 under one year olds ( Fig. 3 A) . This finding was dependent on assuming that we had a high degree of 199 homophily in the social contacts of school-age children (the high within school transmission scenario at ∼6 months old. The rapid increase in per-capita infection rate was due to waning of maternally 215 acquired immunity to RSV, which we inferred as lasting on average 21.6 days ([17.2, 26 .1] 95% CI). 216 The total infection rate within households was greatest in size 5 and 6 households ( Fig. 3 always occurs at the relevant stage of pregnancy. Therefore, we consider both a maximalist scenario 230 (100% MAB coverage), and a more realistic uptake (50% MAB coverage). The number of days of 231 additional maternally derived protection donated to the newborns by MAB vaccinated mothers was 232 uncertain, we considered a range of MAB protection 0 -90 days. We assumed that if the pregnant 233 mother's household cohabitants agreed to receive an immune response provoking vaccine then all 234 were vaccinated. As is common in vaccine strategy analysis we combine coverage and effectiveness 235 into one effective coverage (coverage times effectiveness c.f. Keeling and Rohani (2008) ineffective (0 days MAB protection), we found that it was still possible to reduce RSV hospitalisations 247 by up to 25% using only the IRP vaccine on the household members of young infants at time of 248 birth ( Fig. 4 A and B ). If 100% maternal vaccination could be achieved then the MAB vaccine was 249 more successful as a sole vaccine option compared to IRP vaccination; in the sense that 90 days 250 of additional protection from RSV delivered a 45% reduction in hospitalisation even with no IRP 251 vaccine coverage. Nonetheless, even with an effective MAB vaccine there was added benefit to 252 also using a IRP vaccine; a greater than 50% reduction in hospitalisations was achieved with a 253 MAB vaccine that gave 75 additional days of RSV protection and a 75% coverage of the pregnant 254 womens' households ( Fig. 4 A) . If only 50% maternal vaccination coverage could be achieved then 255 unsurprisingly also using the IRP vaccine became relatively more important. The mixed vaccination 256 strategy that achieved better than 50% hospitalisation reduction with 100% maternal coverage 257 achieved 38% reduction in hospitalisations with 50% maternal coverage ( Fig. 4 B) ; reducing the 258 maternal coverage by half didn't necessarily half the success of the vaccination programme so 259 long as IRP vaccine was also available. Improving the effectiveness of the MAB vaccine caused 260 a significant improvement in hospitalisations, but had an almost negligible effect on the total 261 infections in the population (Fig. 4 C and D) . IRP vaccination was more effective at reducing total 262 RSV infections, but even at 75% coverage of the households of women giving birth the reduction in 263 infections was < 4% ( Fig. 4 C and D). That IRP vaccination had a modest effect on the true infection 264 rate, and that MAB vaccination has a negligible effect on the true infection rate, was in line with 265 the prediction of the simple non-seasonal RSV model (Box 1). However, the simple model could 266 not predict that the percentage reduction in hospitalisations would be significantly greater than for 267 total infections because of the direct and indirect protection of those most at risk of disease. For the 268 mixed strategy achieving a 50% reduction in RSV hospitalisations at 100% MAB coverage described 269 above the seasonal dynamics of hospitalisations post-vaccination were similar to "no intervention" 270 but at a lower rate ( Fig. 5 A) . There was a reduction in median hospitalisations in every age group, 271 but predominantly in 0-3 month years old (who are nearly all protected by the MAB vaccine) and 272 3-6 month year olds ( Fig. 5 B) were vaccinating at a low rate compared to population size, with only a modest reduction in infection 310 rate, those people we did vaccinate were efficient at cocooning young infants from transmission 311 and therefore risk of severe disease. If an effective MAB vaccine was also available the reduction in less since young infants were also protected from contracting RSV at the age when they were at 314 most risk of severe disease. 315 We constructed the model used in this paper with the purpose of estimating the efficacy of 316 targeting pregnant women and their households for vaccination. In order to make predictions 317 mechanistic models of disease transmission must approximate the social structure of the popula-318 tion being modelled, and hence the contact rates between individuals. The focus on household 319 transmission in this paper necessitated including households into the modelled social structure; 320 this represented significant additional effort in model construction, computational resource and 321 inference compared to simpler models. A more common approach in the literature is to treat 322 the contact rates between individuals as being determined only by their respective ages. This 323 approach has the benefit of being conceptually straight-forward and draws on a number of recent 324 and high-quality studies which quantify social contact patterns by age stratification Mossong et al. 325 (2008); Kiti et al. (2014) ; Prem et al. (2017) . However, the fundamental theory of age-structured 326 transmission models for endemic diseases was developed mainly with reference to diseases that 327 induce very long term or lifelong immunity Anderson and May (1992) . For diseases provoking long 328 lasting immunity one would expect most older household members to be immune and there-329 fore household structure to be a relatively less important factor in predicting risk of transmission 330 compared to the age-structured transmission outside of the household. Indeed, simulation study 331 of a generic strongly immunizing infection with realistic demography found limited difference 332 in predicted incidence rate by age for people at schooling age or older between models with 333 household structure and age structure compared to models with only age structure Geard et al. 334 (2015). However, it is not clear that neglecting household structure is a good approximation for 335 modelling seasonal RSV transmission for two reasons: first, previously infected people lose effective 336 immunological protection to RSV rapidly enough that each season could be closer to an 'epidemic' 337 scenario rather than an 'endemic' scenario. Second, every hospital admission at KCH confirmed as 338 due to RSV was a pre-school aged child; in contrast to predicted incidence rates for school age and 339 older individual, the simulation study cited above Geard et al. (2015) predicted that incidence was 340 lower for 0-5 year olds, especially so for under one year olds, once household structure was taken 341 into account. It would be of great interest to have a more general theoretical understanding of 342 which epidemiological questions require household structure, or a more general meta-population 343 structure, for epidemiological modelling, and which don't. This remains an active area of research 344 Ball et al. (2015) . 345 A cocooning protective effect of households could explain the big discrepancy between our 346 estimate of the mean period of protection against RSV after birth due to transplacental transfer 347 of antibodies from mother to baby in the the womb ( (2015) . 372 This was a modelling study and, as ever, there are factors that we have neglected in our analysis 373 that could be addressed in future work. First, we treated coverage of the maternal vaccine and the 374 IRP vaccine as independent. In reality, the simplest and cheapest scenario whereby the household 375 cohabitants of pregnant mothers are recruited to the vaccination programme is if they attend 376 antenatal contact with the mother-to-be late in the pregnancy. Therefore, if many pregnant women 377 in their third trimester, when a MAB vaccine dose is expected to be effective, are missed from 378 the vaccination programme then their household cohabitants would also be missed. paper has been to establish the importance of thinking jointly about hospitalisation risk, population 391 structure (in particular household co-occupancy) and future vaccination programmes. These issues 392 would suggest that RSV vaccination policy would benefit from further cost-benefit analyses tailored 393 to LMIC settings, possibly using more flexible stochastic IBMs with the model parameters inferred 394 in this study. 395 In conclusion, in this paper we have analysed the performance of a joint maternal and household 396 targeting RSV vaccination strategy measuring both reduction in hospitalisations and the true 397 population incidence rate. We drew our conclusions based on rigorous inference of underlying 398 transmission parameters and the inherent protection to RSV newborns received from their mothers, 399 taking into account potential confusing factors such as variable seasonality and demography. Two 400 central insights from our study were that the duration of natural protection to RSV that newborns 401 inherit from their mother was likely to be much shorter than previously estimated and that RSV 402 attack rates within the household were significant in maintaining RSV transmission. Therefore, 403 targeting pregnant women and their households for RSV vaccination is likely to be an effective and 404 efficient strategy under a wide range of different scenarios.
405

Methods
406
The dynamical RSV model used in this paper simulated infection and transmission of RSV among or not were derived as standard, e.g.
.
(1)
The conditional distribution for an individual's household size and whether they lived in a household 447 containing an U1 based on their age was constructed similarly. The reason we included a variable (House and Keeling (2008a) ). Mathematically, the number of households in 462 a given household configuration at time was denoted 1 , 1 , 1 , 2 , 2 , 2 ( ), referring to the household 463 configuration with exactly 1 U1 susceptibles, 1 U1 infecteds etc. In order to limit the number 464 of possible household states we included only households of total size ten or less with two or 465 less under ones. We chose these limits on the household size based on capturing ≈ 99% of the 466 U1s in the population, and therefore the pathway to them catching RSV (Supporting Information). 
Each term describing the vector field of equation (2) 475 2. RSV transmission between households due to age-group specific mixing ( ( ( ))).
476
3. Change in household numbers due to population flux, ( ( ( ))).
477
See Supporting Information for further details. The force of infection due to transmission within a 478 household of generic configuration ( 1 , 1 , 1 , 2 , 2 , 2 ) was 479 ℎℎ = ( )( 1 + 2 2 ).
Where is the basic within-household transmission rate, 2 is the relative decrease in infectiousness to be independent of her household type (see above), but was shifted by conditioning on the age of 510 the U1 being greater than her maternal protection period, 511 ℙ( ∈ | ≤ ).
Which was calculated exactly (see Supporting Information). This took into account that increasing 512 the duration of maternal protection would increase the age at infection and therefore reduce 513 the risk of disease. O1s were assumed to have no maternal protection but their conditional age 514 depended on their household type [equation (1)]. We used these conditional distributions to 515 convert the incidence rate of U1s and O1s in each household type into dynamic incidence rates in 516 each age category,  ( ). By assuming that all O1s had been infected at least once we could use 517 previously published age-dependent hospitalisation odds per infection ℎ (Kinyanjui et al. (2015) 518 and Supporting Information) to determine the cumulative hospitalisations predicted by the model 519 for each age category and week interval = ( ,1 , ,2 ), Information) . We also assumed that there was a vaccine 569 available that provoked an immune response in the vaccinated individuals similar to a natural 570 infection; that is a susceptible 1 who is vaccinated immediately becomes 'recovered' and immune 571 to RSV infection until her immunity waned. Immune response provoking vaccination was offered to 572 all O1s in households when a birth occurred, as an addendum to the antenatal contact between 573 mothers-to-be and health professionals. In principle, there were three dimensions to the coverage 574 of the immunity provoking vaccine: (i) coverage of households, (ii) coverage within households, and 575 (iii) vaccine effectiveness. For simplicity, we bundled these dimensions together, and vaccinated 576 whole households at an effective vaccination rate (the product of the three dimensions of coverage).
577
Model simulations 578 We simulated the model by numerically solving the high dimensional ODE [equation (2) Nie (2017) . For retrospective simulations comparing model predictions to data (Fig. 2) we used 590 the most probable values of the yearly seasonality. For forecast simulations we generated 500 591 realisations of yearly seasonality over 10 years from the distribution inferred in model inference, 592 this gave 500 predictions for the time series of future hospitalisations. We typically presented 593 medians of these predictions (e.g. Fig. 4 ).
RSV is a seasonal virus, in temperate climates the peak month for RSV incidence tends to be consistent year-on-year. Therefore, modelling approaches aimed at understanding RSV transmission in temperate climates have used an annually periodic deterministic function, with the timing of peak infectiousness of RSV being either a model parameter Yamin et al. (2016) or itself a function of climatic variable to be fitted using regression methods Pitzer et al. (2015) . The seasonal drivers of RSV transmission in the tropics are less clear Paynter (2015) . At KCH the most common trough month for RSV hospitalisations was September, which lead us to define the RSV 'year' as September -September. The most common month for peak hospitalisation in each RSV year was January, however there was significant variation in peak month between RSV seasons with peaks occurring in each month November -April between 2002-2016 (Fig 1) . The year-on-year variation in peak month for RSV hospitalisation means that naively inferring a single fixed peak infectiousness parameter would not be a successful inference strategy. However, determining the precise mechanistic reason for shifting seasonality was challenging for the KDHSS population. RSV has been positively associated with the rainy season in some tropical settings Paynter et al. (2012) ; Paynter (2015) , however this is not obviously the case in Kilifi county where the rainy season is April to June with short rains October to December. There have been many proposed mechanisms for erratic periodicity in transmission (for a wide variety of infectious pathogens) which could be relevant to RSV transmission in Kilifi, for example, dynamical attractor switching Keeling et al. (2001) , or the effect of species/strain interaction Bhattacharyya et al. (2018) . In particular, strain competition between RSV A and RSV B has been identified a mechanism for generated complex seasonal dynamics White et al. (1999) . In this paper, we took an agnostic view and rather than choosing a mechanistic hypothesis for erratic seasonality from the many possible, we assume that the time-varying infectiousness of RSV alters randomly (but from a common distribution) year to year: ln ( ) = cos(2 ( − )), ∈ RSV year .
Where the RSV infectiousness ( ) and seasonal peak timing ( ) for each RSV year are drawn jointly from a normal distribution common to each year ( , ) ∼  ( , ). During model inference the yearly and realisations are treated as latent variables; their mean and covariance matrix are imputed along with other model parameters. 
